HR 1475, the SBA Disaster Transparency Act, requires the Small Business Administration (SBA) to publish all disaster assistance reports on its website. This bill amends existing law by adding specific language mandating that the SBA "publish on the website of the Administration" reports related to disaster assistance, including those submitted by state and local officials. The key mechanism is a procedural update to existing reporting requirements, ensuring all required reports are publicly accessible online rather than only being submitted internally. This directly affects the SBA (by changing its reporting process) and the public (by providing greater transparency into how disaster aid is distributed). The bill does not alter disaster assistance eligibility or funding levels.
The DEFUND Act of 2025 would terminate U.S. membership in the United Nations and all its affiliated bodies, including the World Health Organization, by repealing the legal foundations for U.S. participation. It requires the closure of the U.S. Mission to the UN, withdrawal from UN headquarters agreements, and the cessation of all U.S. financial contributions to the UN (except for termination costs). The bill also mandates that UN entities vacate U.S. government properties, revokes diplomatic immunity for UN officials in the U.S., and prohibits U.S. involvement in UN peacekeeping operations. Future U.S. re-entry into the UN would require Senate approval and a reservation allowing for immediate withdrawal.
HR 1488 repeals two laws that authorized U.S. military force against Iraq: the 1991 Gulf War authorization and the 2002 Iraq War authorization. This bill removes the legal basis for military operations under these specific resolutions, directly affecting how future U.S. military actions in Iraq could be justified. The key provision is the direct repeal of both resolutions from federal law, eliminating their continued legal effect. As a result, any new military action in Iraq would require fresh congressional authorization rather than relying on these repealed laws.
HR 1492 amends the Social Security Act to extend the negotiation period for standard drug manufacturers under the federal drug pricing program. Specifically, it changes the timeframe from 7 years to 11 years for small-molecule drugs (like traditional pills) to negotiate prices with the government, aligning it with the existing 12-year period for complex biologic drugs (like insulin or monoclonal antibodies). This adjustment directly affects pharmaceutical companies that produce small-molecule drugs, giving them a longer window to negotiate pricing terms. The bill makes this change effective as if it had been part of the 2022 law that established the program.
This bill would require states to create a simplified process for out-of-state healthcare providers to join Medicaid and CHIP programs. Qualified providers (those already enrolled in Medicare or another state's program with low fraud risk) could enroll without excessive screening and would be approved for five years. It directly affects children under 21 enrolled in Medicaid or CHIP by expanding access to providers outside their state, particularly in underserved areas. The change applies to all states' Medicaid programs but takes effect three years after enactment.
HR 1463 prohibits the use of federal funds to implement, administer, or enforce a specific FDA rule about medical devices known as "laboratory developed tests" (LDTs), published in the Federal Register on May 6, 2024 (89 Fed. Reg. 37286). The bill directly affects the Food and Drug Administration (FDA), preventing it from using taxpayer money to carry out this regulation. Its key mechanism is a straightforward funding ban on the specified rule and any substantially similar future rule. This is a procedural restriction focused solely on blocking financial support for the FDA's LDT regulatory approach.
S 664, the NIH Reform Act, reorganizes the National Institutes of Health (NIH) by splitting the former "National Institute of Allergy and Infectious Diseases" into three separate institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. The bill establishes new director positions for each institute with 5-year terms (allowing one reappointment), replaces the old institute's name in all federal references, and transfers existing responsibilities for related research areas to the new entities. This restructuring affects NIH's internal management and leadership, streamlining focus on specific disease areas without altering research funding or public health policies. The changes take effect upon the bill's enactment, with the NIH Director overseeing the transition until new institute directors are appointed.
This bill prohibits U.S. federal funding for foreign governments identified as imposing severe penalties - including death sentences or life imprisonment - for apostasy, blasphemy, or interfaith marriage. Within 120 days of enactment, the President must submit a report listing countries meeting these criteria, based on credible evidence. U.S. assistance to any country named in this report is then banned, directly affecting foreign aid programs and the governments of those nations. The law targets specific policy changes in U.S. foreign aid disbursement, not broader diplomatic or humanitarian efforts.
This bill protects certain public safety workers - like police officers, firefighters, and emergency medical personnel - from job loss or punishment for expressing personal opinions about work-related issues. It allows covered employees to sue employers if they face adverse actions (like termination) for speaking out on topics such as working conditions, safety equipment, pay, policies, or even political/religious views. However, the protection does not cover speech made while on duty, threats of violence, discrimination, disclosure of confidential personal information, or calls to withhold essential services. The law explicitly states it doesn’t override existing civil rights laws like 42 U.S.C. 1983.
HR 1432, the LIABLE Act, removes federal immunity for manufacturers of authorized COVID-19 vaccines regarding claims of injury or loss from vaccine administration or use. It directly affects vaccine manufacturers by allowing individuals to pursue civil lawsuits for vaccine-related harm, regardless of prior compensation through existing programs like the National Vaccine Injury Compensation Program. The bill explicitly overrides previous laws (such as sections 319F-3, 2111, and 2122 of the Public Health Service Act) that previously limited manufacturer liability. This law applies retroactively to all vaccine administration or use occurring before, during, or after the bill’s enactment.
HR 1410 expands access to mental health care for 9/11 responders and survivors by allowing licensed mental health providers (not just physicians) to conduct initial health evaluations and certifications under the World Trade Center Health Program. It adjusts the program’s funding formula to account for changing enrollment numbers by linking annual funding to the previous year’s enrollment ratio, and clarifies that deceased individuals are excluded from enrollment counts. The bill also extends the timeframe for adding new health conditions to the program’s list and requires a 2028 report assessing long-term funding needs through 2090. These changes aim to streamline eligibility, improve care access, and ensure sustainable funding for the program.
HR 1436, the ENABLE Act, makes permanent key tax provisions for ABLE accounts - tax-advantaged savings accounts for people with disabilities. It removes the 2026 expiration date for increased contribution limits to ABLE accounts and allows rollovers from 529 college savings plans into ABLE accounts without tax penalties. These changes directly affect individuals with disabilities who use ABLE accounts for qualified expenses like housing, education, and medical costs. The bill ensures these financial tools remain available long-term, streamlining access to savings without requiring new legislative action each year.
